The FDA has approved a douching device that gently cleanses.
Results of a double-blind placebo-controlled study of women complaining of vaginal odor (but not due to infection or other medical causes), showed that participants who were randomized to WaterWorks experienced a significant reduction (P<.05) and/or elimination of vaginal odor compared to those using placebo. As always, advise patients to see you first to rule out common/treatable odor-causing vaginal infections. For more information or to purchase, call (800)-231-4928 or go to http://www.waterworkshealth.com/ . The product is not available in stores.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More